Angelika Florvaag, kvalitetssjef i Hofseth Biocare ASA, har i dag 30.12.2016 kjøpt 10.000 aksjer til snittkurs 1,20 pr aksje i Hofseth BioCare ASA. Etter dette har Angelika Florvaag 10.000 aksjer i Hofseth BioCare ASA, tilsvarende 0,004 % av aksjene i Hofseth BioCare ASA.
Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12
Recommended Reading
-
Hofseth BioCare ASA ("HBC" or the "Company") today announces the appointment of Leif Arne Giske as new Chief Financial Officer (CFO) of the HBC Group, effective immediately. Mr. Giske has been with...
Read More -
HBC recorded total operating revenues of NOK 65.7 million in the second quarter of 2026, compared to NOK 68.4 million in the same period last year. Net operating revenues were NOK 63.1 million, down...
Read More